Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
APOTEEK GINDERBUITEN from Mol, company number BE0426798515, closed financial year 2025 with a result of € 35,956 after tax. For that financial year APOTEEK GINDERBUITEN recorded a gross margin of € 304,987 and equity of € 111,052. Compared with financial year 2024, the result moved from € 186,388 to € 35,956. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 111,052
▲ 48% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 35,956
▼ 81% vs 2024
Profit after tax over the fiscal year.
€ 115,501
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 92,452.
People and assets in 2025
2.6
Average over the fiscal year, from the social balance sheet.
€ 228,867
▲ 14% vs 2024
€ 88,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,852
▼ 50% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 224,219
Loans from banks and other lenders, long and short.
€ 247,624
▲ 157% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 41,752
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 501,095 | € 466,559 | € 486,607 | € 304,987 | ▼ 37% |
| Profit after taxes | € 217,387 | € 183,281 | € 186,388 | € 35,956 | ▼ 81% |
| Equity | € 70,426 | € 73,708 | € 75,096 | € 111,052 | ▲ 48% |
| Total debts | € 589,463 | € 554,383 | € 590,670 | € 581,145 | ▼ 2% |
| Cash | € 190,714 | € 153,112 | € 159,206 | € 115,501 | ▼ 27% |
| Retained profit | € 51,826 | € 55,108 | € 56,496 | € 92,452 | ▲ 64% |
| Dividend | € 210,000 | € 180,000 | € 185,000 | € 0 | ▼ 100% |
| Bank debt | € 233,732 | € 224,167 | € 224,167 | € 224,219 | |
| Balance sheet total | € 659,889 | € 628,091 | € 665,766 | € 692,197 | ▲ 4% |
| Employees (FTE) | 2.5 | 2.6 | 2.6 | 2.6 |
By gross margin, APOTEEK GINDERBUITEN ranks 7th of 12 companies with main activity “Detailhandel in farmaceutische producten” in Mol that publish figures (fiscal year 2025).
Key figures of APOTEEK GINDERBUITEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about APOTEEK GINDERBUITEN the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to APOTEEK GINDERBUITEN?
What happened at APOTEEK GINDERBUITEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 35,956 (▼ 81% vs 2024). Source: NBB ↗
- TOMKAT BV became a director. NBB
- New establishment in Mol. KBO
- Start of the company according to the CBE. KBO
In short
From € 217,387 profit in 2022 to € 35,956 profit in 2025.
Paid € 220,627 in corporate taxes since 2022.
Best year ever: 2022, with € 217,387 profit.
On average € 117,300 of value added per employee in 2025.
Management
The stake of TOMKAT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTEEK GINDERBUITENBehind APOTEEK GINDERBUITEN is TOMKAT BV. The shares are held by TOMKAT (0%).
Establishments
Establishment units
Physical locations of this company
Ginderbuiten 119
2400 Mol
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Mol
Same main activity (Detailhandel in farmaceutische producten), 11 active companies in Mol, largest first.
€ 1 million gross margin · 2025
€ 628,378 gross margin · 2025
€ 472,425 gross margin · 2025
€ 367,354 gross margin · 2025
€ 332,315 gross margin · 2025
€ 329,416 gross margin · 2025
Details
- Company number
- 0426.798.515
- VAT number
- BE 0426.798.515
- Registered office
- Ginderbuiten 119, 2400 Mol
- Names & denominations
- APOTEEK GINDERBUITEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 January 1985
- Peppol
- Active · Active since 4 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers